Capstone Investment Advisors LLC purchased a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,289 shares of the biotechnology company’s stock, valued at approximately $482,000. Other institutional investors also […]
Research analysts at Wolfe Research initiated coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) in a report released on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $44.00 price target on the biotechnology company’s stock. Wolfe Research’s price target points to a potential upside of 51.05% from the […]
Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 12-Month High at $27 40 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alpine Immune Sciences (NASDAQ:ALPN) Sets New 1-Year High at $27 40 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 3,980,000 shares, an increase of 32.7% from the December 15th total of 3,000,000 shares. Based on an average daily volume of 788,500 shares, the short-interest […]